AIMS: Angiotensin-converting enzyme 2 (ACE2) is an important negative regulator of the renin-angiotensin system. Loss of ACE2 enhances the susceptibility to heart disease but the mechanism remains elusive. We hypothesized that ACE2 deficiency activates the NADPH oxidase system in pressure overload-induced heart failure. METHODS AND RESULTS: Using the aortic constriction model, we subjected wild-type (Ace2(+/y)), ACE2 knockout (ACE2KO, Ace2(-/y)), p47(phox) knockout (p47(phox)KO, p47(phox-)(/-)), and ACE2/p47(phox) double KO mice to pressure overload. We examined changes in peptide levels, NADPH oxidase activity, gene expression, matrix metalloproteinases (MMP) activity, pathological signalling, and heart function. Loss of ACE2 resulted in enhanced susceptibility to biomechanical stress leading to eccentric remodelling, increased pathological hypertrophy, and worsening of systolic performance. Myocardial angiotensin II (Ang II) levels were increased, whereas Ang 1-7 levels were lowered. Activation of Ang II-stimulated signalling pathways in the ACE2-deficient myocardium was associated with increased expression and phosphorylation of p47(phox), NADPH oxidase activity, and superoxide generation, leading to enhanced MMP-mediated degradation of the extracellular matrix. Additional loss of p47(phox) in the ACE2KO mice normalized the increased NADPH oxidase activity, superoxide production, and systolic dysfunction following pressure overload. Ang 1-7 supplementation suppressed the increased NADPH oxidase and rescued the early dilated cardiomyopathy in pressure-overloaded ACE2KO mice. CONCLUSION: In the absence of ACE2, biomechanical stress triggers activation of the myocardial NAPDH oxidase system with a critical role of the p47(phox) subunit. Increased production of superoxide, activation of MMP, and pathological signalling leads to severe adverse myocardial remodelling and dysfunction in ACE2KO mice.
AIMS: Angiotensin-converting enzyme 2 (ACE2) is an important negative regulator of the renin-angiotensin system. Loss of ACE2 enhances the susceptibility to heart disease but the mechanism remains elusive. We hypothesized that ACE2 deficiency activates the NADPH oxidase system in pressure overload-induced heart failure. METHODS AND RESULTS: Using the aortic constriction model, we subjected wild-type (Ace2(+/y)), ACE2 knockout (ACE2KO, Ace2(-/y)), p47(phox) knockout (p47(phox)KO, p47(phox-)(/-)), and ACE2/p47(phox) double KO mice to pressure overload. We examined changes in peptide levels, NADPH oxidase activity, gene expression, matrix metalloproteinases (MMP) activity, pathological signalling, and heart function. Loss of ACE2 resulted in enhanced susceptibility to biomechanical stress leading to eccentric remodelling, increased pathological hypertrophy, and worsening of systolic performance. Myocardial angiotensin II (Ang II) levels were increased, whereas Ang 1-7 levels were lowered. Activation of Ang II-stimulated signalling pathways in the ACE2-deficient myocardium was associated with increased expression and phosphorylation of p47(phox), NADPH oxidase activity, and superoxide generation, leading to enhanced MMP-mediated degradation of the extracellular matrix. Additional loss of p47(phox) in the ACE2KO mice normalized the increased NADPH oxidase activity, superoxide production, and systolic dysfunction following pressure overload. Ang 1-7 supplementation suppressed the increased NADPH oxidase and rescued the early dilated cardiomyopathy in pressure-overloaded ACE2KO mice. CONCLUSION: In the absence of ACE2, biomechanical stress triggers activation of the myocardial NAPDH oxidase system with a critical role of the p47(phox) subunit. Increased production of superoxide, activation of MMP, and pathological signalling leads to severe adverse myocardial remodelling and dysfunction in ACE2KO mice.
Authors: Gavin Y Oudit; Zamaneh Kassiri; Mikin P Patel; Mark Chappell; Jagdish Butany; Peter H Backx; Robert G Tsushima; James W Scholey; Rama Khokha; Josef M Penninger Journal: Cardiovasc Res Date: 2007-04-21 Impact factor: 10.787
Authors: Michael A Crackower; Renu Sarao; Gavin Y Oudit; Chana Yagil; Ivona Kozieradzki; Sam E Scanga; Antonio J Oliveira-dos-Santos; Joan da Costa; Liyong Zhang; York Pei; James Scholey; Carlos M Ferrario; Armen S Manoukian; Mark C Chappell; Peter H Backx; Yoram Yagil; Josef M Penninger Journal: Nature Date: 2002-06-20 Impact factor: 49.962
Authors: Ulf Landmesser; Hua Cai; Sergey Dikalov; Louise McCann; Jinah Hwang; Hanjoong Jo; Steven M Holland; David G Harrison Journal: Hypertension Date: 2002-10 Impact factor: 10.190
Authors: Karsten Grote; Inna Flach; Maren Luchtefeld; Elvan Akin; Steven M Holland; Helmut Drexler; Bernhard Schieffer Journal: Circ Res Date: 2003-05-15 Impact factor: 17.367
Authors: Christophe Heymes; Jennifer K Bendall; Philippe Ratajczak; Alison C Cave; Jane-Lise Samuel; Gerd Hasenfuss; Ajay M Shah Journal: J Am Coll Cardiol Date: 2003-06-18 Impact factor: 24.094
Authors: Vaibhav B Patel; Abhijit Takawale; Tharmarajan Ramprasath; Subhash K Das; Ratnadeep Basu; Maria B Grant; David A Hall; Zamaneh Kassiri; Gavin Y Oudit Journal: J Mol Med (Berl) Date: 2015-04-15 Impact factor: 4.599
Authors: Vaibhav B Patel; Sreedhar Bodiga; Ratnadeep Basu; Subhash K Das; Wang Wang; Zuocheng Wang; Jennifer Lo; Maria B Grant; JiuChang Zhong; Zamaneh Kassiri; Gavin Y Oudit Journal: Circ Res Date: 2012-04-03 Impact factor: 17.367
Authors: Ratnadeep Basu; Jiwon Lee; Zuocheng Wang; Vaibhav B Patel; Dong Fan; Subhash K Das; George C Liu; Rohan John; James W Scholey; Gavin Y Oudit; Zamaneh Kassiri Journal: Am J Physiol Renal Physiol Date: 2012-08-15
Authors: J Zheng; G Li; S Chen; J Bihl; J Buck; Y Zhu; H Xia; E Lazartigues; Y Chen; J E Olson Journal: Neuroscience Date: 2014-05-09 Impact factor: 3.590
Authors: Tomo Yoshizumi; Yang Zhu; Hongbin Jiang; Antonio D'Amore; Hirokazu Sakaguchi; Jason Tchao; Kimimasa Tobita; William R Wagner Journal: Biomaterials Date: 2015-12-15 Impact factor: 12.479